Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video‐based analysis
Identifieur interne : 002398 ( Main/Exploration ); précédent : 002397; suivant : 002399Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video‐based analysis
Auteurs : C. Warren Olanow [États-Unis] ; Jean-Michel Gracies [États-Unis] ; Christopher G. Goetz [États-Unis] ; A. Jon Stoessl [Canada] ; Thomas Freeman [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; James Godbold [États-Unis] ; Jose A. Obeso [Espagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2009-02-15.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Antiparkinson Agents (adverse effects), Cell Transplantation (methods), Double-Blind Method, Dyskinesia, Dyskinesia, Drug-Induced (diagnosis), Dyskinesia, Drug-Induced (etiology), Dyskinesias (diagnosis), Dyskinesias (etiology), Female, Humans, Levodopa (adverse effects), Male, Middle Aged, Nervous system diseases, Parkinson Disease (complications), Parkinson Disease (drug therapy), Parkinson Disease (surgery), Parkinson disease, Parkinson's disease, Risk Factors, Risk factor, Severity of Illness Index, Substantia Nigra (cytology), Substantia Nigra (embryology), Substantia Nigra (transplantation), Transplantation, Videotape Recording, dyskinesia, fetal nigral transplantion.
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Levodopa.
- complications : Parkinson Disease.
- cytology : Substantia Nigra.
- diagnosis : Dyskinesia, Drug-Induced, Dyskinesias.
- drug therapy : Parkinson Disease.
- embryology : Substantia Nigra.
- etiology : Dyskinesia, Drug-Induced, Dyskinesias.
- methods : Cell Transplantation.
- surgery : Parkinson Disease.
- transplantation : Substantia Nigra.
- Double-Blind Method, Female, Humans, Male, Middle Aged, Risk Factors, Severity of Illness Index, Videotape Recording.
Abstract
The objective of this study is to assess dyskinesias in 34 Parkinson's disease patients randomized to receive bilateral fetal nigral transplantation with 4 donors per side (12), 1 donor per side (11), or placebo (11). Videotape recordings were performed at the baseline, 3, 6, 12, 18, and 24 month visits during the “practically defined off” (12 hours after last evening dopaminergic therapy) and “best on” (best response following morning dopaminergic therapy) states. Videotapes were analyzed in random order by a blinded investigator. Dyskinesias during “best on” (on‐medication dyskinesia) were observed in all, but 1 patient at baseline, and in all patients at each subsequent visit. There were no differences between groups. No patient had dyskinesia at baseline in “practically‐defined off” (“off‐medication” dyskinesia). Following transplantation, off‐medication dyskinesia was observed in 13 of 23 patients, but not in any patient in the placebo group (P = 0.019). There was no difference in dyskinesia score between patients in the 1 and 4 donor groups. On‐medication dyskinesias were typically generalized and choreiform, whereas off‐medication dyskinesias were usually repetitive, stereotypic movements in the lower extremities with residual Parkinsonism in other body regions. Off‐medication dyskinesias are common following transplantation and may represent a prolonged form of diphasic dyskinesias. © 2008 Movement Disorder Society
Url:
DOI: 10.1002/mds.22208
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000B40
- to stream Istex, to step Curation: 000B40
- to stream Istex, to step Checkpoint: 001000
- to stream PubMed, to step Corpus: 001F35
- to stream PubMed, to step Curation: 001F35
- to stream PubMed, to step Checkpoint: 001F01
- to stream Ncbi, to step Merge: 002429
- to stream Ncbi, to step Curation: 002429
- to stream Ncbi, to step Checkpoint: 002429
- to stream Main, to step Merge: 002C59
- to stream PascalFrancis, to step Corpus: 000F70
- to stream PascalFrancis, to step Curation: 001D49
- to stream PascalFrancis, to step Checkpoint: 000F51
- to stream Main, to step Merge: 003048
- to stream Main, to step Curation: 002398
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video‐based analysis</title><author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name></author><author><name sortKey="Gracies, Jean Ichel" sort="Gracies, Jean Ichel" uniqKey="Gracies J" first="Jean-Michel" last="Gracies">Jean-Michel Gracies</name></author><author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name></author><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name></author><author><name sortKey="Freeman, Thomas" sort="Freeman, Thomas" uniqKey="Freeman T" first="Thomas" last="Freeman">Thomas Freeman</name></author><author><name sortKey="Kordower, Jeffrey H" sort="Kordower, Jeffrey H" uniqKey="Kordower J" first="Jeffrey H." last="Kordower">Jeffrey H. Kordower</name></author><author><name sortKey="Godbold, James" sort="Godbold, James" uniqKey="Godbold J" first="James" last="Godbold">James Godbold</name></author><author><name sortKey="Obeso, Jose A" sort="Obeso, Jose A" uniqKey="Obeso J" first="Jose A." last="Obeso">Jose A. Obeso</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6B1524778BF557305FB50FEFBD59B5C7FA061850</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/mds.22208</idno><idno type="url">https://api.istex.fr/document/6B1524778BF557305FB50FEFBD59B5C7FA061850/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000B40</idno><idno type="wicri:Area/Istex/Curation">000B40</idno><idno type="wicri:Area/Istex/Checkpoint">001000</idno><idno type="wicri:doubleKey">0885-3185:2009:Olanow C:clinical:pattern:and</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:19006186</idno><idno type="wicri:Area/PubMed/Corpus">001F35</idno><idno type="wicri:Area/PubMed/Curation">001F35</idno><idno type="wicri:Area/PubMed/Checkpoint">001F01</idno><idno type="wicri:Area/Ncbi/Merge">002429</idno><idno type="wicri:Area/Ncbi/Curation">002429</idno><idno type="wicri:Area/Ncbi/Checkpoint">002429</idno><idno type="wicri:Area/Main/Merge">002C59</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:09-0136786</idno><idno type="wicri:Area/PascalFrancis/Corpus">000F70</idno><idno type="wicri:Area/PascalFrancis/Curation">001D49</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000F51</idno><idno type="wicri:doubleKey">0885-3185:2009:Olanow C:clinical:pattern:and</idno><idno type="wicri:Area/Main/Merge">003048</idno><idno type="wicri:Area/Main/Curation">002398</idno><idno type="wicri:Area/Main/Exploration">002398</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video‐based analysis</title><author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mount Sinai School of Medicine, New York, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Gracies, Jean Ichel" sort="Gracies, Jean Ichel" uniqKey="Gracies J" first="Jean-Michel" last="Gracies">Jean-Michel Gracies</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mount Sinai School of Medicine, New York, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurological Sciences, Rush‐Presbyterian St. Luke's Medical Center, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Neurology, University of British Columbia, Vancouver, British Columbia</wicri:regionArea><wicri:noRegion>British Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Freeman, Thomas" sort="Freeman, Thomas" uniqKey="Freeman T" first="Thomas" last="Freeman">Thomas Freeman</name><affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurosurgery, University of South Florida, Tampa, Florida</wicri:regionArea><placeName><region type="state">Floride</region><settlement type="city">Tampa</settlement></placeName><orgName type="university">Université de Floride du Sud</orgName></affiliation></author><author><name sortKey="Kordower, Jeffrey H" sort="Kordower, Jeffrey H" uniqKey="Kordower J" first="Jeffrey H." last="Kordower">Jeffrey H. Kordower</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurological Sciences, Rush‐Presbyterian St. Luke's Medical Center, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Godbold, James" sort="Godbold, James" uniqKey="Godbold J" first="James" last="Godbold">James Godbold</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Obeso, Jose A" sort="Obeso, Jose A" uniqKey="Obeso J" first="Jose A." last="Obeso">Jose A. Obeso</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Neurology and Neurosurgery, Clinica Universitaria and Medical School, Neuroscience Centre and CIBERNED, University of Navarra and CIMA, Pamplona</wicri:regionArea><wicri:noRegion>Pamplona</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-02-15">2009-02-15</date><biblScope unit="vol">24</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="336">336</biblScope><biblScope unit="page" to="343">343</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">6B1524778BF557305FB50FEFBD59B5C7FA061850</idno><idno type="DOI">10.1002/mds.22208</idno><idno type="ArticleID">MDS22208</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (adverse effects)</term><term>Cell Transplantation (methods)</term><term>Double-Blind Method</term><term>Dyskinesia</term><term>Dyskinesia, Drug-Induced (diagnosis)</term><term>Dyskinesia, Drug-Induced (etiology)</term><term>Dyskinesias (diagnosis)</term><term>Dyskinesias (etiology)</term><term>Female</term><term>Humans</term><term>Levodopa (adverse effects)</term><term>Male</term><term>Middle Aged</term><term>Nervous system diseases</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (surgery)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Risk Factors</term><term>Risk factor</term><term>Severity of Illness Index</term><term>Substantia Nigra (cytology)</term><term>Substantia Nigra (embryology)</term><term>Substantia Nigra (transplantation)</term><term>Transplantation</term><term>Videotape Recording</term><term>dyskinesia</term><term>fetal nigral transplantion</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Substantia Nigra</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dyskinesia, Drug-Induced</term><term>Dyskinesias</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="embryology" xml:lang="en"><term>Substantia Nigra</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term><term>Dyskinesias</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Cell Transplantation</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="transplantation" xml:lang="en"><term>Substantia Nigra</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Risk Factors</term><term>Severity of Illness Index</term><term>Videotape Recording</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Dyskinésie</term><term>Facteur risque</term><term>Maladie de Parkinson</term><term>Pathologie du système nerveux</term><term>Transplantation</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study is to assess dyskinesias in 34 Parkinson's disease patients randomized to receive bilateral fetal nigral transplantation with 4 donors per side (12), 1 donor per side (11), or placebo (11). Videotape recordings were performed at the baseline, 3, 6, 12, 18, and 24 month visits during the “practically defined off” (12 hours after last evening dopaminergic therapy) and “best on” (best response following morning dopaminergic therapy) states. Videotapes were analyzed in random order by a blinded investigator. Dyskinesias during “best on” (on‐medication dyskinesia) were observed in all, but 1 patient at baseline, and in all patients at each subsequent visit. There were no differences between groups. No patient had dyskinesia at baseline in “practically‐defined off” (“off‐medication” dyskinesia). Following transplantation, off‐medication dyskinesia was observed in 13 of 23 patients, but not in any patient in the placebo group (P = 0.019). There was no difference in dyskinesia score between patients in the 1 and 4 donor groups. On‐medication dyskinesias were typically generalized and choreiform, whereas off‐medication dyskinesias were usually repetitive, stereotypic movements in the lower extremities with residual Parkinsonism in other body regions. Off‐medication dyskinesias are common following transplantation and may represent a prolonged form of diphasic dyskinesias. © 2008 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Canada</li><li>Espagne</li><li>États-Unis</li></country><region><li>Floride</li><li>Illinois</li><li>État de New York</li></region><settlement><li>Tampa</li></settlement><orgName><li>Université de Floride du Sud</li></orgName></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name></region><name sortKey="Freeman, Thomas" sort="Freeman, Thomas" uniqKey="Freeman T" first="Thomas" last="Freeman">Thomas Freeman</name><name sortKey="Godbold, James" sort="Godbold, James" uniqKey="Godbold J" first="James" last="Godbold">James Godbold</name><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name><name sortKey="Gracies, Jean Ichel" sort="Gracies, Jean Ichel" uniqKey="Gracies J" first="Jean-Michel" last="Gracies">Jean-Michel Gracies</name><name sortKey="Kordower, Jeffrey H" sort="Kordower, Jeffrey H" uniqKey="Kordower J" first="Jeffrey H." last="Kordower">Jeffrey H. Kordower</name></country><country name="Canada"><noRegion><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name></noRegion></country><country name="Espagne"><noRegion><name sortKey="Obeso, Jose A" sort="Obeso, Jose A" uniqKey="Obeso J" first="Jose A." last="Obeso">Jose A. Obeso</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002398 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002398 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6B1524778BF557305FB50FEFBD59B5C7FA061850
|texte= Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video‐based analysis
}}
| This area was generated with Dilib version V0.6.23. |  |